Animalcare Group Plc(ANCR)
GBX --+0.00%
Reward44Moderate
Risk25Low
📊75%Data
Thin 4% profit margin · Revenue growing 19% YoY
ANCR
+0.0 · +0.00%
GBX · LSE
Animalcare Group Plc | Healthcare
Balanced
Market Cap:229.23M
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
25
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on ANCR to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: 307p.

What is Animalcare Group Plc?

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

ANCR · Verdict

Moderate reward · low risk

ANCR stands out on cash flow and volatility, but watch the growth signal.

Based on 88% data coverage

ANCR · Verdict

What’s working & what to watch

Strengths 3

  • Cash flow85/100

    16% free-cash-flow margin

  • Volatility80/100

    Top decile vs peers

  • Balance sheet75/100

    Interest covered 12.6×

Watchouts 2

  • Growth36/100

    Revenue +0.1% CAGR

  • Valuation40/100

    P/E 24.0×

Model-based scoring. For information only — not financial advice.

What is Animalcare Group Plc?

Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets. The company has a collaboration with 272Bio Limited to develop and commercialize a novel biological treatment for a common equine skin condition, known as sweet itch. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 229.23M, and a P/E ratio of 83.0x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with profitability and momentum offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap229.23M
P/E Ratio83
Dividend Yield1.57%
52 Week High340
52 Week Low213.9429
Last AnnualJune
IPO Date1/15/2008
IncorporatedUK
Shares Outstanding69M
No. of Employees201
IndustryDrug Manufacturers - Specialty & Generic
ExchangeLSE
Beta0.491
CurrencyGBX · Reports in GBP